Genetic variants of APOE and CCR4 as determinants of myocardial infarction among type 2 diabetes patients: a South Indian case–control analysis | Synapse
March 3, 2026
Genetic variants of APOE and CCR4 as determinants of myocardial infarction among type 2 diabetes patients: a South Indian case–control analysis
Key Points
Myocardial infarction rates were significantly linked to APOE and CCR4 variants in type 2 diabetes patients.
The study identified specific genetic variants that contribute to increased risk of myocardial infarction, including those in the APOE and CCR4 genes.
Analysis focused on South Indian patients with type 2 diabetes, revealing novel associations between genetic variants and myocardial infarction risk.
Understanding these genetic influences may lead to targeted prevention strategies for myocardial infarction in type 2 diabetes individuals.